Regional Events

The ARUP Institute for Learning is committed to supporting educational events that advance the practice of laboratory medicine and improve quality patient care by providing guest speakers at local and regional meetings. Listed below are the current events where the Institute for Learning is providing sponsored speakers.


Chérie V. Petersen

Customer Service: What’s in it for Me?

This workshop speaks to the commitment each and every one of us needs to embrace in order to put customer service best practices into action. There is no doubt, and no shortage of statistical proof, that exceptional customer service is the differentiating factor in market growth, customer retention, and basic industry competitiveness. But if employees don’t connect the direct personal benefits of service-oriented behaviors to their own job satisfaction, and even their personal satisfaction, there can only be little hope for progress. Participants will be able to recognize the positive outcomes related to a personal commitment to service excellence principles. They will engage in activities specifically design to create a paradigm shift—moving them from executing activities mandated by management in an effort to simply fulfill their job responsibilities, to regarding the practice of service excellence principles as a means of validating their value to patients and physicians, co-workers, their laboratory organization, and, more importantly, their own self-worth.


Casey Leavitt, MBA

Implementing a Test Utilization Management Program: Combining Medicine and Management

This presentation will examine test utilization from both a medical and managerial perspective, focusing on information that guides utilization management efforts, such as inappropriate test ordering, and how tiering can be used to guide interventions. Also discussed will be various interventions used to control utilization, including their advantages and disadvantages, as well as managerial approaches to the implementation of a successful utilization program. Finally, case studies illustrating how effective utilization management can reduce costs and improve the quality of care will be presented.


Rhonda Hensley

Rapid Rewards: Using Molecular Diagnostics in Positive Blood Cultures

Will Microbiology soon see more instrumentation? Rapid identification of organisms may dramatically change patient treatment, reduce length of stay, and save healthcare dollars. In this session we will discuss new molecular methods for rapid ID’s directly from positive blood culture such as Nanosphere, FilmArray, Maldi-Tof and discuss the potential benefits these systems may have on patient treatment.

Microbiology News, New, and Nuances

Using an interactive game style we’ll review microbiology case studies that have made the news, are newly emerging, and/or are nuances of organisms we may encounter clinically in ways we don’t think of. Identify the likely pathogen based on clinical and laboratory clues. Answer the question and crack the case.


Suzanne Carasso, MBA, MT(ASCP)

The Value of the Laboratory: Invest or Outsource?

The anemic economic recovery, in combination with the impact of national healthcare reform, is putting pressure on the healthcare industry to navigate reductions in reimbursement, implement cost-cutting initiatives and improve patient outcomes and quality of life. Changing the way healthcare is delivered and paid for is the new imperative.

Laboratories, now more than ever before, have a unique opportunity to substantially impact both short and long term sustainability of hospitals and health systems. However, the old paradigm still exists in many organizations where the lab is viewed as a commodity. As such, some systems are selling laboratory and outreach operations to private equity firms, joint venture capitalists or national laboratories in exchange for an immediate and significant infusion of cash. It follows that laboratories failing to demonstrate value to the organization face an uncertain future.

This presentation will inform attendees of the industry trends that are influencing these decisions, the risks laboratories face and what labs can do to demonstrate value in tangible ways.

FEB
6
Details Winter Education Seminar
Grand Junction, CO

Harry R. Hill, MD

Star Wars of the Body Besieged: A Review of Immunology and Immunodeficiency

Dr. Hill relates the major portions of the body’s host defense system to the military’s Star Wars that protects us from external and internal invaders. He describes the laboratory assays utilized to assess each portion of the immune and inflammatory system. Lastly, he shows individual patients he has seen over the past 40 years in his Clinical Immunology/ Immunodeficiency Clinic at University of Utah which illustrate the various immune defects and the infections they suffer. He presents this in a manner so one can understand this complex system, know how to evaluate it and use in the clinical laboratory to help these seriously affected patients.

Wilderness Medicine for the Laboratorian

Dr. Hill describes the many wilderness hazards he has encountered in numerous climbing, hiking, and backcountry skiing events in the Teton, Cascade Mountains and in Alaska including severe lightning storms, bear encounters, hypothermia, severe allergic reactions, snake exposure, trauma and gastrointestinal infection. He suggests ways these encounters might be avoided or managed so that one survives!


Anne E. Tebo, PhD

Laboratory Evaluation of Celiac Disease/ Gluten Sensitivity

Celiac disease (CD) is an autoimmune disorder that occurs in genetically susceptible individuals of all ages and is triggered by immune response to gluten and related proteins. The disease is characterized by variable combination of gluten-dependent clinical manifestations, the presence of specific, HLA-DQ2 and/or DQ8 haplotypes and enteropathy. This presentation will be covered in two separate modules. During the first module the presenter will discuss the immunopathogenesis, classification, clinical features, and epidemiology of CD. In the second part, current guidelines and serologic tests for laboratory evaluation will be presented. The presenter will also discuss the challenges regarding the use of specific CD serologic assays and how laboratories may help mitigate these problems.


Charles D. Hawker, PhD, MBA, FACB

Achieving Six-Sigma Quality in Clinical Laboratory Non-Analytic Metrics: The Role of Automation

Although many clinical laboratories have utilized Lean and Six Sigma techniques to improve quality, actually achieving Six Sigma quality (= 3.4 defects per million opportunities or DPMO) has proven extremely challenging. Most laboratories’ error rates are in the Five Sigma range. This presentation will discuss how ARUP has utilized sophisticated automation and process re-engineering to reduce lost specimens by nearly 100-fold to levels that have been at Six Sigma quality in nine different months during the past few years.


Chérie V. Petersen

Communication Biohazard

The laboratory plays an invaluable and enormously significant role in patient care. Given the laboratory’s valuable, what’s the one thing that could destroy it in a heartbeat? Communication issues! Laboratorians have all of this great, specialized expertise; however, sometimes the delivery sabotages the value. This session engages participants in a highly energetic, narrowly focused, interactive, humorous approach that allows them the opportunity to distinguish some of the bio-hazardous communications they engage in and then address more effective strategies to communicate their information, knowledge, and expertise.


Elizabeth L. Frank, PhD

Laboratory Assessment of Renal Calculi

Nephrolithiasis, the formation of kidney stones, is a common condition that develops due to a variety of environmental, metabolic, and genetic factors. In this session, laboratory tests used to evaluate risk for formation of kidney stones and techniques used to determine composition of calculi will be discussed.


Elizabeth L. Frank, PhD

Porphyrins and Porphyrias

The porphyrias are a group of rare diseases associated with defects in the biosynthetic pathway of heme. Heme biosynthesis and the porphyrias will be discussed in this session. Laboratory testing for diagnosis of porphyrias will be reviewed.